Hormone Replacement Therapy in Postmenopausal Women

Joyce P. Griffin-Sobel

ONF 2003, 30(5), 747-749. DOI: 10.1188/03.ONF.747-749

Jump to a section


    Grady, D. (2003). Postmenopausal hormones—Therapy for symptoms only. New England Journal of Medicine, 348, 1835-1837.

    Hays, J., Ockene, J., Brunner, R., Kotchen, J., Manson, J., Patterson, R., et al. (2003). Effects of estrogen plus progestin on health-related quality of life. New England Journal of Medicine, 348, 1839-1854.

    Lacey, J., Mink, P., Lubin, J., Sherman, M., Troisi, R., Hartge, P., et al. (2002). Menopausal hormone replacement therapy and risk of ovarian cancer in a prospective study. JAMA, 288, 334-341.

    Monson, J., & Martin, K. (2001). Postmenopausal hormone replacement therapy. New England Journal of Medicine, 345, 34-40.

    National Institutes of Health. (2002). Postmenopausal hormone therapy. Retrieved July 11, 2003, from http://www.nhlbi.nih.gov/health/women/index.htm

    O'Meara, E., Rossing, M., Daling, J., & Elmore, J. (2001). Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality. Journal of the National Cancer Institute, 93, 754-762.

    Rodriguez, C., Patel, A., Callee, E., Jacob, E., & Thun, M. (2001). Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of U.S. women. JAMA, 285, 1460-1465.

    Ross, R., Paganini-Hill, A., & Wan, P. (2000). Effective hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. Journal of the National Cancer Institute, 92, 328-332.

    Schairer, C., Lubin, J., Troisi, R., Sturgeon, S., Brinton, L., & Hoover, R. (2000). Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA, 283, 485-491.

    Solomon, C., & Dluhy, R. (2003). Rethinking postmenopausal hormone therapy. New England Journal of Medicine, 348, 579-580.

    U.S. Department of Health and Human Services. (2001). Menopause: One woman's story, every woman's story [NIH Publication No. 01-3886]. Retrieved July 16, 2003, from http://www.nia.nih.gov/health/pubs/menopause/menopause.pdf

    Writing Group for the Women's Health Initiative Investigators. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA, 288, 321-333.

    Zibecchi, L., Greendale, G., & Ganz, P. (2003). Comprehensive menopausal assessment: An approach to managing vasomotor and urogenital symptoms in breast cancer survivors. Oncology Nursing Forum, 30, 393-405.

    Brandenburg, S. (2002). Hormone replacement therapy: Questions and controversies. Primary Care Case Reviews, 5(1), 2-7.

    Chen, C., Weiss, N., Newcomb, P., Barlow, W., & White, E. (2002). Hormone replacement therapy in relation to breast cancer. JAMA, 287, 734-741.

    Goldsmith, J. (2002). Cutting through the HRT confusion. American Journal of Nursing, 102(9), 20.

    Grodstein, F., Clarkson, T., & Manson, J. (2003). Understanding the divergent data on postmenopausal hormone therapy. New England Journal of Medicine, 348, 645-650.

    Laine, C. (2002). Postmenopausal hormone replacement therapy: How could we have been so wrong? Annals of Internal Medicine, 137, 290.

    Rapp, S.R., Espeland, M.A., Schumaker, S.A., Henderson, V.W., Brunner, R.L., Manson, J.E., et al. (2003). Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: A randomized clinical trial. JAMA, 289, 2663-2672.